Sponsor:
Jonsson Comprehensive Cancer Center
Code:
NCT04201873
Conditions
Recurrent Glioblastoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Dendritic Cell Tumor Cell Lysate Vaccine
Pembrolizumab
Placebo Administration
Poly ICLC
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations